Skip to main content

Find Clinical Trials

Home
Conditions
Liver Fibrosis

Clinical trial condition

Liver Fibrosis

Explore clinical trials studying Liver Fibrosis. Study availability and eligibility vary by location and protocol.

126 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Liver Fibrosis trial results

Completed

Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients

NCT00926224

Conditions: Cirrhosis, Digestive System Diseases, Fibrosis, +5 more
Locations: Calgary University Hospital Calgary, Alberta, Canada

London University Hospital London, Ontario, Canada

Toronto Western General Hospital Toronto, Ontario, Canada

Toronto Liver Centre Toronto, Ontario, Canada

View Trial Details

Completed

Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis

NCT00956098

Conditions: Digestive System Diseases, Fibrosis, Liver Cirrhosis, +4 more
Locations: The Catholic University of Korea Holy Family Hospital Sosa-Dong, Wonmi-Gu, Gyeonggi-do, South Korea

The Catholic University of Korea Seoul St. Mary's Hospital Banpo-Dong, Seocho-Gu, Seoul, South Korea

View Trial Details

Completed

Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C

NCT00298714

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis

NCT00043303

Conditions: Blood-Borne Infections, Cirrhosis, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

Patients With Primary Biliary Cholangitis(PBC)

NCT07629128

Conditions: Bile Duct Diseases, Biliary Tract Diseases, Blood Sugar; High, +16 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli Roma, Italy

View Trial Details

Active, Not Recruiting

Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota

NCT03863730

Conditions: Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Liver Disease, +12 more
Locations: FLASH - Centre of Liver Research Odense, Fyn, Denmark

Odense University Hospital Odense, Denmark

View Trial Details